Review



primary antibodies against p fak  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc primary antibodies against p fak
    Primary Antibodies Against P Fak, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 541 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against p fak/product/Cell Signaling Technology Inc
    Average 96 stars, based on 541 article reviews
    primary antibodies against p fak - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    90
    ZenBio primary antibodies against phosphorylated focal adhesion kinase (zenbio, p-fak)
    Primary Antibodies Against Phosphorylated Focal Adhesion Kinase (Zenbio, P Fak), supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against phosphorylated focal adhesion kinase (zenbio, p-fak)/product/ZenBio
    Average 90 stars, based on 1 article reviews
    primary antibodies against phosphorylated focal adhesion kinase (zenbio, p-fak) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc primary antibodies against p fak
    Primary Antibodies Against P Fak, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against p fak/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    primary antibodies against p fak - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against cleaved parp, p-fak (tyr397), p-akt (ser473), p-jnk (thr183/tyr185), p-erk1/2 (thr202/try204), and gapdh
    Primary Antibodies Against Cleaved Parp, P Fak (Tyr397), P Akt (Ser473), P Jnk (Thr183/Tyr185), P Erk1/2 (Thr202/Try204), And Gapdh, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cleaved parp, p-fak (tyr397), p-akt (ser473), p-jnk (thr183/tyr185), p-erk1/2 (thr202/try204), and gapdh/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against cleaved parp, p-fak (tyr397), p-akt (ser473), p-jnk (thr183/tyr185), p-erk1/2 (thr202/try204), and gapdh - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Signalway Antibody primary antibodies against p-fak
    Inhibition effect of LHT on the cellular proliferation and migration through VEGF receptor, ERK and <t>FAK</t> pathways. ( A ) Multiple signaling pathways from the VEGF-A/VEGFR2 interaction to induce cellular migration and proliferation. LHT inhibits VEGF-A/VEGFR2 binding through VEGF-A/LHT interactions. ( B ) Western blot (cropped blots) of cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Full-length blots were presented in . ( C ) Quantitative analysis of <t>Western</t> <t>blotting</t> bands cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Data were expressed with mean ± s.e.m. (n = 3). * p < 0.05, *** p < 0.001 versus the VEGF-treated group.
    Primary Antibodies Against P Fak, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against p-fak/product/Signalway Antibody
    Average 90 stars, based on 1 article reviews
    primary antibodies against p-fak - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences primary antibodies against p-fak (rabbit polyclonal
    Inhibition effect of LHT on the cellular proliferation and migration through VEGF receptor, ERK and <t>FAK</t> pathways. ( A ) Multiple signaling pathways from the VEGF-A/VEGFR2 interaction to induce cellular migration and proliferation. LHT inhibits VEGF-A/VEGFR2 binding through VEGF-A/LHT interactions. ( B ) Western blot (cropped blots) of cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Full-length blots were presented in . ( C ) Quantitative analysis of <t>Western</t> <t>blotting</t> bands cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Data were expressed with mean ± s.e.m. (n = 3). * p < 0.05, *** p < 0.001 versus the VEGF-treated group.
    Primary Antibodies Against P Fak (Rabbit Polyclonal, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against p-fak (rabbit polyclonal/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    primary antibodies against p-fak (rabbit polyclonal - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against p-fak
    Inhibition effect of LHT on the cellular proliferation and migration through VEGF receptor, ERK and <t>FAK</t> pathways. ( A ) Multiple signaling pathways from the VEGF-A/VEGFR2 interaction to induce cellular migration and proliferation. LHT inhibits VEGF-A/VEGFR2 binding through VEGF-A/LHT interactions. ( B ) Western blot (cropped blots) of cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Full-length blots were presented in . ( C ) Quantitative analysis of <t>Western</t> <t>blotting</t> bands cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Data were expressed with mean ± s.e.m. (n = 3). * p < 0.05, *** p < 0.001 versus the VEGF-treated group.
    Primary Antibodies Against P Fak, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against p-fak/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against p-fak - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against gapdh, akt, p-akt, erk1/2, p-erk1/2, fak, p-fak, src, and p-src
    Inhibition effect of LHT on the cellular proliferation and migration through VEGF receptor, ERK and <t>FAK</t> pathways. ( A ) Multiple signaling pathways from the VEGF-A/VEGFR2 interaction to induce cellular migration and proliferation. LHT inhibits VEGF-A/VEGFR2 binding through VEGF-A/LHT interactions. ( B ) Western blot (cropped blots) of cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Full-length blots were presented in . ( C ) Quantitative analysis of <t>Western</t> <t>blotting</t> bands cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Data were expressed with mean ± s.e.m. (n = 3). * p < 0.05, *** p < 0.001 versus the VEGF-treated group.
    Primary Antibodies Against Gapdh, Akt, P Akt, Erk1/2, P Erk1/2, Fak, P Fak, Src, And P Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against gapdh, akt, p-akt, erk1/2, p-erk1/2, fak, p-fak, src, and p-src/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against gapdh, akt, p-akt, erk1/2, p-erk1/2, fak, p-fak, src, and p-src - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against p-fak y86
    <t>FAK</t> activity is required and activated by Src under stimulation. (A) FAK kinase activity FRET biosensor. The higher the activity, the lower the FRET index. (B) FRET index (averaged over the whole cell) of the stably expressed FAK biosensor in unstimulated ( n = 593), 4-h HGF-treated ( n = 183), PF228-treated ( n = 455), PP1-treated ( n = 392) cells, single cells ( n = 74), and 4-h HGF-treated single cells ( n = 108), confluent cells ( n = 91), and 4- to 5-h HGF-treated confluent cells ( n = 202). ns, not significant. (C) Top: FAK domain organization and tyrosine sites. Bottom: Typical Western blot from lysates of unstimulated and HGF-treated (3 h) with or without PP1 or PF228. (D) Phosphorylation levels FAK <t>Y397,</t> Y576/577, Y861 normalized to total FAK level from Western blots of cells treated as in panel c ( n = 7 lysates). (E) Top: Typical micrographs of GFP-β-catenin cells with and without HGF and PF228. Bottom: Area after 2 h normalized by the area at t = 0 for unstimulated cells, HGF-treated (data from Fig. S1 I), and HGF- and PF228-treated cells ( n = 10 cells). (F) GFP intensity in the nucleus (relative to cytoplasm) of GFP-β-catenin 5 h with or without HGF (50 ng/ml; data from ), and with PF228 (10 µM) with or without HGF ( n = +/− 37/43 cells). (G) FRET index change of EcadTSMod in cells 5 h with and without HGF (50 ng/ml; data from ), and with PF228 (25 µM) with or without HGF ( n = +/− 110/99 cells). (H) Top: Typical micrographs of wounded sheet migration of GFP-β-catenin cells with and without (same control as in ) PF228 (25 µM). Bottom: Migration speed (mean distance traveled by cell front per hour) with or without (same control as ) PF228 (25 µM; n = 121 cells). Bars: (wound healing) 100 µm; (FAK sensor) 20 µm. Two-tailed Mann–Whitney or Kruskal–Wallis tests. Values plotted are mean ± SEM.
    Primary Antibodies Against P Fak Y86, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against p-fak y86/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against p-fak y86 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Inhibition effect of LHT on the cellular proliferation and migration through VEGF receptor, ERK and FAK pathways. ( A ) Multiple signaling pathways from the VEGF-A/VEGFR2 interaction to induce cellular migration and proliferation. LHT inhibits VEGF-A/VEGFR2 binding through VEGF-A/LHT interactions. ( B ) Western blot (cropped blots) of cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Full-length blots were presented in . ( C ) Quantitative analysis of Western blotting bands cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Data were expressed with mean ± s.e.m. (n = 3). * p < 0.05, *** p < 0.001 versus the VEGF-treated group.

    Journal: Cancers

    Article Title: Anticancer Effect of Heparin–Taurocholate Conjugate on Orthotopically Induced Exocrine and Endocrine Pancreatic Cancer

    doi: 10.3390/cancers13225775

    Figure Lengend Snippet: Inhibition effect of LHT on the cellular proliferation and migration through VEGF receptor, ERK and FAK pathways. ( A ) Multiple signaling pathways from the VEGF-A/VEGFR2 interaction to induce cellular migration and proliferation. LHT inhibits VEGF-A/VEGFR2 binding through VEGF-A/LHT interactions. ( B ) Western blot (cropped blots) of cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Full-length blots were presented in . ( C ) Quantitative analysis of Western blotting bands cell lysate of HUVECs after cultivation with VEGF (10 ng/mL) or VEGF with LHT (100 µg/mL) for 24 h. Data were expressed with mean ± s.e.m. (n = 3). * p < 0.05, *** p < 0.001 versus the VEGF-treated group.

    Article Snippet: Then, Western blotting was carried out for checking the phosphorylation of VEGFR, ERK1/2 and FAK molecules with primary antibodies against ERK1/2 (Santa Cruz Biotechnology, Inc., Dallas, TX, USA), p-ERK1/2 (Santa Cruz Biotechnology), FAK (Signalway Antibody LLC., College Park, MD, USA), p-FAK (Signalway Antibody LLC), VEGFR (Abcam), p-VEGFR (Abcam) followed by incubation with horseradish peroxidase-conjugated secondary antibodies.

    Techniques: Inhibition, Migration, Protein-Protein interactions, Binding Assay, Western Blot

    FAK activity is required and activated by Src under stimulation. (A) FAK kinase activity FRET biosensor. The higher the activity, the lower the FRET index. (B) FRET index (averaged over the whole cell) of the stably expressed FAK biosensor in unstimulated ( n = 593), 4-h HGF-treated ( n = 183), PF228-treated ( n = 455), PP1-treated ( n = 392) cells, single cells ( n = 74), and 4-h HGF-treated single cells ( n = 108), confluent cells ( n = 91), and 4- to 5-h HGF-treated confluent cells ( n = 202). ns, not significant. (C) Top: FAK domain organization and tyrosine sites. Bottom: Typical Western blot from lysates of unstimulated and HGF-treated (3 h) with or without PP1 or PF228. (D) Phosphorylation levels FAK Y397, Y576/577, Y861 normalized to total FAK level from Western blots of cells treated as in panel c ( n = 7 lysates). (E) Top: Typical micrographs of GFP-β-catenin cells with and without HGF and PF228. Bottom: Area after 2 h normalized by the area at t = 0 for unstimulated cells, HGF-treated (data from Fig. S1 I), and HGF- and PF228-treated cells ( n = 10 cells). (F) GFP intensity in the nucleus (relative to cytoplasm) of GFP-β-catenin 5 h with or without HGF (50 ng/ml; data from ), and with PF228 (10 µM) with or without HGF ( n = +/− 37/43 cells). (G) FRET index change of EcadTSMod in cells 5 h with and without HGF (50 ng/ml; data from ), and with PF228 (25 µM) with or without HGF ( n = +/− 110/99 cells). (H) Top: Typical micrographs of wounded sheet migration of GFP-β-catenin cells with and without (same control as in ) PF228 (25 µM). Bottom: Migration speed (mean distance traveled by cell front per hour) with or without (same control as ) PF228 (25 µM; n = 121 cells). Bars: (wound healing) 100 µm; (FAK sensor) 20 µm. Two-tailed Mann–Whitney or Kruskal–Wallis tests. Values plotted are mean ± SEM.

    Journal: The Journal of Cell Biology

    Article Title: Src- and confinement-dependent FAK activation causes E-cadherin relaxation and β-catenin activity

    doi: 10.1083/jcb.201706013

    Figure Lengend Snippet: FAK activity is required and activated by Src under stimulation. (A) FAK kinase activity FRET biosensor. The higher the activity, the lower the FRET index. (B) FRET index (averaged over the whole cell) of the stably expressed FAK biosensor in unstimulated ( n = 593), 4-h HGF-treated ( n = 183), PF228-treated ( n = 455), PP1-treated ( n = 392) cells, single cells ( n = 74), and 4-h HGF-treated single cells ( n = 108), confluent cells ( n = 91), and 4- to 5-h HGF-treated confluent cells ( n = 202). ns, not significant. (C) Top: FAK domain organization and tyrosine sites. Bottom: Typical Western blot from lysates of unstimulated and HGF-treated (3 h) with or without PP1 or PF228. (D) Phosphorylation levels FAK Y397, Y576/577, Y861 normalized to total FAK level from Western blots of cells treated as in panel c ( n = 7 lysates). (E) Top: Typical micrographs of GFP-β-catenin cells with and without HGF and PF228. Bottom: Area after 2 h normalized by the area at t = 0 for unstimulated cells, HGF-treated (data from Fig. S1 I), and HGF- and PF228-treated cells ( n = 10 cells). (F) GFP intensity in the nucleus (relative to cytoplasm) of GFP-β-catenin 5 h with or without HGF (50 ng/ml; data from ), and with PF228 (10 µM) with or without HGF ( n = +/− 37/43 cells). (G) FRET index change of EcadTSMod in cells 5 h with and without HGF (50 ng/ml; data from ), and with PF228 (25 µM) with or without HGF ( n = +/− 110/99 cells). (H) Top: Typical micrographs of wounded sheet migration of GFP-β-catenin cells with and without (same control as in ) PF228 (25 µM). Bottom: Migration speed (mean distance traveled by cell front per hour) with or without (same control as ) PF228 (25 µM; n = 121 cells). Bars: (wound healing) 100 µm; (FAK sensor) 20 µm. Two-tailed Mann–Whitney or Kruskal–Wallis tests. Values plotted are mean ± SEM.

    Article Snippet: Proteins were transferred to nitrocellulose (Whatman), blocked, and probed with primary antibodies against FAK, p-FAK Y397, p-FAK Y576/577, p-FAK Y86 (610088; BD Sciences; 11765; Santa Cruz Biotechnologies; 3281P; Cell Signaling Technology; and 44626; Invitrogen, respectively) or primary antibodies against E-cadherin, β-catenin, or α-tubulin (clone 36-610181; BD Sciences; CM1181; ECM Biosciences; and T9026; Sigma-Aldrich).

    Techniques: Activity Assay, Stable Transfection, Western Blot, Phospho-proteomics, Migration, Control, Two Tailed Test, MANN-WHITNEY